Cargando…
Discovery of a small-molecule inhibitor of the TRIP8b–HCN interaction with efficacy in neurons
Major depressive disorder is a critical public health problem with a lifetime prevalence of nearly 17% in the United States. One potential therapeutic target is the interaction between hyperpolarization-activated cyclic nucleotide–gated (HCN) channels and an auxiliary subunit of the channel named te...
Autores principales: | Han, Ye, Iyamu, Iredia D., Clutter, Matthew R., Mishra, Rama K., Lyman, Kyle A., Zhou, Chengwen, Michailidis, Ioannis, Xia, Maya Y., Sharma, Horrick, Luan, Chi-Hao, Schiltz, Gary E., Chetkovich, Dane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243175/ https://www.ncbi.nlm.nih.gov/pubmed/35623388 http://dx.doi.org/10.1016/j.jbc.2022.102069 |
Ejemplares similares
-
HCN channel dendritic targeting requires bipartite interaction with TRIP8b and regulates antidepressant-like behavioral effects
por: Han, Ye, et al.
Publicado: (2016) -
TRIP8b Is Required for Maximal Expression of HCN1 in the Mouse Retina
por: Pan, Yuan, et al.
Publicado: (2014) -
Modulation of thalamocortical oscillations by TRIP8b, an auxiliary subunit for HCN channels
por: Zobeiri, Mehrnoush, et al.
Publicado: (2017) -
The structure and function of TRIP8b, an auxiliary subunit of hyperpolarization-activated cyclic-nucleotide gated channels
por: Han, Ye, et al.
Publicado: (2020) -
CRAFTing a New Approach to Antiepileptic Drug Discovery
por: Lyman, Kyle A., et al.
Publicado: (2019)